Document B8vmDDd9NxXOMgpov30OZxdVw
TEH 0412515
WjfegStJI**,'--
(
a i/*-//yfr
2 4 S V QW
% WV.
/ if "\
/
\
CC: 3. M. Pierrard-E5D-L135G W. F. Wagner-ESD-L2305 D. W. Marquardt-ESD-L51B6 IC 52 - Applied Statistics
March 17, 1986
3,, G. PARTAIN CHEMICALS 4 PIGMENTS BRANDYWINE 16254
CASAC MEETING ON AIR QUALITY CRITERIA FOR LEAD - TRIP REPORT
I attended the meeting of the Clean Air Scientific Advisory Committee (CASAC) of EPA's Science Advisory Board on March 11-12, 1986 and presented public comments (attached) on Du Pont's analyses of the blood pressure-blood lead (BP-BPb) association reflected in the draft Addendum. The oral comments were drawn from the written comments, which you previously received, prepared by 3ack Pierrard and myself on the Addendum.
The meeting agenda and list of CASAC members are attached. The purpose of the meeting was for CASAC to review the February 1986 Addendum to the Air Quality Criteria Document for Lead, which is based on recently published information relating blood lead to blood pressure and stature; and, to review the Lead Staff Paper, which is intended to evaluate and interpret the most critical scientific and technical information from the Criteria Document leading to a revision of the National Ambient Air Quality Standard for Lead. Our comments discussed at the May 9, 1985 CASAC Meeting were well received and led to relegation of the BP-BPb discussion then in the Corrigenda to an Addendum subject to review of Du Pont's comments. Our oral comments on March 12, 1986 were mainly directed at the EPA initiated review process on our analyses of May 9, 1985.
Not unexpectedly, we were unable to achieve our ultimate goal, deletion of the Addendum. However, our comments and presence were felt. Dr. Ware, CASAC statistical consultant, acknowledged the importance of the issues raised by Du Pont and the results provided, stated he was not persuaded that a BP-BPb association exists by the evidence at hand, and recommended more work should be done to resolve the significance and magnitude of the BP-BPb association with Du Pont's involvement. We also received support from other members of CASAC as well as support in writing by other statisticians reviewing EPA's analyses and Du Pont's. My 15 minute presentation extended to 45 minutes with discussion. The important benefit of our comments and participation is that
C. G. Pfeifer
TEH 0412516
DUP050453568
N 30998.01
2 March 17, 1986 Jo 8 . r*art ain
our position and the supporting comments are a fully documented part of the public record. A transcript of the proceedings has been requested for future reference.
CASAC was extremely critical of the Staff Paper and requested major revisions. Some favorable comments were expressed on the probability risk assessment material.
Dr. Gale Hoffnagle, TRC, presented public comments for Lead Industries Association on Exposure to Airborne Lead From Stationary Sources; An Evaluation of Proposed National Ambient Air Quality Standards for Lead. Included in this report is a cost-benefit analysis on compliance costs for the TEL facility at Chambers Works for meeting a 0.5^g/nr standard. Compliance costs are estimated at $6.5MM opposite benefits of $63M.
Follow-up to this meeting is as follows;
o CASAC requested that EPA revise Addendum to more fairly present scientific findings in time for CASAC meeting in April 1986. Then CASAC will be prepared to close on both the Criteria Document and the Addendum for publication and distribution. This time frame, if met, precludes any further resolution of the issues raised by Du Pont. There will be no public review of this Addendum revision.
o Another draft of the Staff Paper is required and CASAC will meet to review it. A public comment period probably will occur, although it was not mentioned specifically.
o Revised primary and secondary National Ambient Air Quality Standards for Lead are expected to be promulgated in mid 1987.
There are a variety of future activities that Jack and I perhaps should be involved in. These include;
o Comments on Current Staff Paper due May 1986.
o Comments on revised Addendum. Although this will not be available for public review, I requested. Dr. Grant, ECAO Director, send me a copy of this revision. If a balanced view of BP-BPb is not given, it will be critical to respond in time before CASAC closes on the Addendum. This would be our last chance to impact on it.
o Dr. Grant and Dr. Lippman will ask for Du Pont1s involvement in a process to resolve the magnitude of the BP-BPb effect, if these effects are to be used by OAQPS in assessing cardiovascular risk.
o Don Diggs and others have strongly suggested we publish our results refuting the BP-BPb association portrayed in key papers of Harlan, et al (1985) and Pirkle, et al (1985).
o There undoubtedly will be a comment period on the next revision of the staff paper.
TEH 0412517
C. G. Pfeifer
DUP050453569
March 17, 1y06 J. 8. Par tain
We need your guidance on the extent to which you wish Jack and I to pursue these activities. I believe our efforts and involvement on the BP-BPb association have been critical to establishing a defensible position on this health-effect issue. Our present work request will be nearly exhausted as a result of the most recent efforts. Please advise on your support of continued efforts for representing Du Pont on lead regulation issues. ENGINEERING SERVICE DIVISION Applied Statistics Group C. G. Pfeifer Consultant Supervisor CGP:lsw Atchs 5.9
TEH 0412518
DUP050453570
i i'':i r /
r-: <- r,;..
lean Air Scientific: Advisory Cs'srrsr'i
Lead NAAQS Review Committee
U.S. E.P.A. Environmental Research Center
Main Auditorium Alexander Drive and Route 54
Research Triangle Park, NC
Open Meeting - March 11-12, 1986
Tuesday, March 11 9:30 a.m.
9:45 11:30 11:45
1:00 p.m.
1:30 3:00 3:15 4:30
Welcome and Opening Remarks
Dr. Lippmann, CASAC Chairman
Discussion of the Addendum to the Lead Criteria Document
Dr. Grant, ECAO Dr. Weil, ECAO
Brief Presentation of Regression on Blood Lead and Blood Pressure
Dr. Joel Schwartz, OP PE
Lunch
Introduction and Overview of the Lead Staff Paper
Mr. O'Connor, OAQPS Mr. Jordan, OAQPS Mr. Haines, OAQPS Mr. Cohen, OAQPS
Discussion of Staff Paper
Break
Exposure Analysis and Discussion
Ms. Sledge, OAQPS
Comments from the Public
- Dr. Jerome Cole, ILZRO
- Dr. Gale Hoffnagle, TRC
- Dr. Harvey Gonick, Cedars Sinai Medical Center
- Mr. Richard Smith, U.S. Bureau of Mines
- Dr. Charles Pfeifer, du Pont
5:30
Recess
7:00
CASAC Dinner at Slugs-at-the-Pines (Cash Bar at 7:00, Dinner at 8:00)
TEH 0412519
DUP050453571
Wednesday, March 12
9:00 a.m.
Lead Risk Assessment
10:00
Break
10:15
Committee Discussion
11:00
Summarization - Review of Closure Issues - Future Activities
12:30 p.m.
Adjourn
Dr. Wallsten Dr. Whitfield
Dr. Lippmann
TEH 0412520
DUP050453572
V
4.
U.S. ENVIRONMENTAL PRO'Ii.CT ION AGENCY CLEAN AIR SCIENTIFIC ADVISORY COMMITTEE
SCIENCE ADVISORY BOARD
Subcommittee on Lead
Chairman
Dr. Morton Lippmann Professor Department of Environmental
Medicine NYU Medical Center Tuxedo, New York 10987
ji& -E--x--e--c--u--t-iv--e----S--e--c--r-e--t-a--ry
/y
t^Mr. Robert Flaak '^Science Advisory Board (A-101F)
U.S. Environmental Protection Agency
401 M Street, S.W. Washington, D.C. 20460
Panel Members
*yf Dr. Carol R. Angle ^ Professor of Pediatrics and
Director UNMC Toxicology Program University of Nebraska Medical Center COP - Room 4037A 42nd and Dewey Avenue Omaha, Nebraska 68105
l/t)r. Robert Frank
^/Professor of Environmental Health Sciences
Johns Hopkins School of Hygiene and Public Health
615 N. Wolfe Street Baltimore, Maryland 21205
'/y Dr. J. Julian Chisolm, Jr.
\s Associate Professor of Pediatrics The Kennedy Institute 707 North Boardway Baltimore, Maryland 21205
Prof. A. Myrick Freeman III Department of Economics Bowdoin College
Brunswick, Maine 04011
* Dr. Anita S. Curran Commissioner Westchester County Health Department 112 East Post Road White Plains, New York 10601
\/y Dr. Robert Goyer Deputy Director NIEHS P.0. 12233 RTp ] North Carolina
27709
*/, Dr. Ben B. Ewing l/ Professor of Environmental Engineering
Institute for Environmental Studies University of Illinois 408 S. Goodwin Urbana, Illinois 61801
Dr. Paul B. Hammond y Professor of Environmental Health
University of Cincinnati College of Medicine
Kettering Laboratory 3223 Eden Avenue Cincinnati, Ohio 45267-0056
TEH 0412521
DUP050453573
s. \` Ll'iyn li. Ih j it !;ihrevs y/ Professor Lmrritus
University of Illinois Urbana-Champaign 603 East Daniel Champaign, Illinois 61820
y * Dr. Warren B. Johnson y. Director, Atmospheric Science
Center SRI International 333 Ravenswood Avenue Menlo Park, California 94025
i Dr. Paul Kotin
X Adjunct Professor of Pathology University of Colorado Medical School 4505 S. Yosemite #339 Denver, Colorado 80237
yj Dr. Timothy Larson
Environmental Engineering and Science Program
Department of Civil Engineering FX-10
University of Washington Seattle, Washington 98195
Dr. Kathryn R. Mahaffey
v Chief, Priorities Research and
Analysis Branch (C-15) NI0SH 4676 Columbia Parkway Cincinnati, Ohio 45226
Prof. M. Granger Morgan
v Head, Department of Engineering
and Public Policy Carnegie-Mel Ion University Pittsburgh, Pennsylvania 15253
* Unable to attend meeting
( f ' ^1 o i
. itV* I \
v' lAparLinen! of Lconomics
Stanford University
Stanford, California 94305
X Dr. D. Warner North y. Principal
Decision Focus Inc., Los Altos Office Center, Suite 200
4984 El Camino Real Los Altos, California 94022
^Dr. Robert D. Rowe ice President, Environmental and Resource Economics
Energy and Resource Consultants Inc. 207 Canyon Boulevard Boulder, Colorado 80302
% * Prof. Richard M. Royal!
K Department of Biostatistics Johns Hopkins University 615 North Wolfe Street Baltimore, Maryland 21205
v/yDr. Ellen K. Silbergeld
%/ Chief Toxics Scientist
Toxic Chemicals Program Environmental Defense Fund 1525 18th Street, N.W. Washington, D.C. 20036
Dr. James H. Ware / Associate Professor
Harvard School of Public Health Department of Biostatistics 677 Huntington Avenue Boston, Massachusetts 02115
V/Dr. Jerry Wesolowski I/Air and Industrial Hygiene Lab
California Department of Health 2151 Berkeley Way Berkeley, California 94704*
TEH 0412522
DUP050453574